Tagged with

Neurotech Pharmaceuticals What was the vision behind the creation of Neurotech back in 1998, originally as a Research Center, and then as an independent bio-tech company? It all began in 1998 when special new laws were passed by the Korean government aiming to get professors to contribute to the development of the…

Astellas Pharma Germany Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks to the merger of the two companies. Could you describe their integration process in Germany and which were the main synergies in the local market?…

Berlin Chemie/Menarini When we met Dr. Aleiotti in Italy, he said how important was Menarini´s acquisition of Berlin Chemie in the 1990s for the internationalization of the company in Eastern Europe and Central Asia. As the CEO of Berlin Chemie for the last seven years, what would you highlight as the main…

Gilead Sciences Germany Gilead was founded in 1987 and only four years later it established itself in the German market. Since then the company has become internationally known for breakthroughs that resulted in products such as Tamiflu, Viread and Atripla. What would you highlight as the main achievements of the company in the…

Shin Poong Pharm Could you please introduce Shinpoong, which you founded in 1962, and mention the main milestones of this unique company in the Korean pharmaceutical industry? I founded Shinpoong in a very delicate and decisive time for Korea. During the civil war the population had to face serious epidemics, and by the…

Korea Health Industry Development Institute What is KHIDI’s role in supporting the development of the Korean health industry? KHIDI performs three major roles in supporting the Korean health industry, which includes pharmaceuticals, medical devices, cosmetics, functional food and medical care. First role is developing the health system and policies. The next role is funding R&D…

VGX International Could you briefly introduce VGX International to our readers, and in particular explain its relation to US-based company VGX Pharmaceutical (VGXP)? The backbone of VGXP is the University of Pennsylvania in terms of the research grant and Dr. David Weiner as the scientific chief of the company and the brain…

SOHO Group For the last six years Soho Group has been the fastest growing pharmaceutical company in Indonesia, able to position itself among the top players in the industry. What have been the key characteristics that made the company stand out from the competition? The factors enabling us to achieve those results…

CNR Since 1982, CNR has been the Italian public body which most contributed to the creation of inventions and innovations. What have been the main strategies behind such a success in sustaining Italy’s evolution towards a more knowledge based economy? CNR, which used to act as a funding agency in the…

The appointment of Lino Barañao and the establishment of the Ministry of Science and Technology suggest that the government has realised what a large role innovation can play in the Argentine economy. As an institute that has been working in this field for many years now, how do you feel…

generics “The ball is in the hands of the government,” according to Giorgio Foresti, general manager of Ratiopharm. “Once aware of the opportunities created by generics, politicians will have to make hard decisions.” Until now, generics prescriptions were limited by strong links between innovators and doctors, and price alignment trends reducing…

The pharmaceutical industry arose from science – and so did Italy’s knowledge based economy. Building on a reputation for innovation carved in the 15th century, when Leonardo Da Vinci, Michelangelo, Galileo and other icons of the Italian Renaissance helped shape the modern world, the country’s life science industry is now…